Nicholas Blondin

Nicholas A. Blondin, MD, is an Assistant Professor of Clinical Neurology at Yale School of Medicine and a practicing neurologist specializing in neuro-oncology. He provides patient care at Smilow Cancer Hospital in New Haven and its Trumbull Care Center, focusing on benign/malignant brain tumors, metastasis, and cancer-related neurological symptoms.

• University of Connecticut School of Medicine (MD)
• Yale New Haven Hospital (Neurology Residency/Chief Resident)
• Yale New Haven Hospital (Neuro-Oncology Fellowship)

His research focuses on neuro-oncology, clinical trials methodology, and metabolic imaging of brain tumors, with particular interest in immunotherapy complications, novel diagnostic assays, and molecular characterization of metastatic disease. Recent publications highlight adaptive platform trials and metabolic biomarkers in glioblastoma.

Scientific Awards:

• Connecticut Brain Tumor Alliance Humanitarian Award (2018)
• Cigna Care Designation (2017)
• UnitedHealth Premium Designation (2017)
• Palatucci Advocacy Leadership Forum Graduate (2014)
• Gold Humanism Honor Society (2013)

Dr. Blondin serves as Principal Investigator in multiple clinical trials, including studies of NanO2™ with radiation, NX-5948 BTK degrader, and Tirabrutinib for PCNSL. He maintains active collaborations with researchers at the Yale Biomedical Imaging Institute and Yale Cancer Center.